| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers S > Headlines for StemCells Inc. > News item |
StemCells moves to Nasdaq National Market
New York, Sept. 30 - StemCells, Inc. said the Nasdaq Stock Market has approved its application to list on the Nasdaq National Market.
It will continue to trade under its current ticker, "STEM."
"Our move to the Nasdaq National Market reflects the continued maturation of StemCells, Inc. as a publicly traded company," said Martin McGlynn, president and chief executive officer, in a news release. "We believe our listing on the National Market will better serve investors by providing greater liquidity and visibility for our shares."
The Palo Alto, Calif., biotechnology company previously traded on the Nasdaq Capital Market, formerly the Nasdaq SmallCap Market.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.